A polypeptide drug carrier for maternal delivery and prevention of fetal exposure. - Wikidata - wikimedia - TriplyDB

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

http://www.wikidata.org/entity/Q34490667

about

Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct Corneal Penetrating Elastin-Like Polypeptide Carriers.Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.A kidney-selective biopolymer for targeted drug delivery.Placental control of drug delivery.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.The Use of Ex Vivo Whole-organ Imaging and Quantitative Tissue Histology to Determine the Bio-distribution of Fluorescently Labeled Molecules.Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.Pro-angiogenic therapeutics for preeclampsia

P2860

Q26766128-523CD673-96F3-452C-8CAC-8E4990EB642C Q34140082-DA2C1E4F-B9AA-4307-BADC-2163007FB4E6 Q35047445-6E80AB76-52EE-40ED-A73A-7EA41037AD20 Q36036258-A0DE92F0-7871-4FAD-A79E-E244C15F852E Q36944671-F39AC58B-E623-4FAF-9487-BB2B3E87CEE6 Q37081322-C7CC35F9-4EE7-4DDD-BE38-6B37060A701E Q37248790-D5FCD19A-C90D-4E18-8755-459E2211AAE0 Q38636559-20E48665-9D04-4EE8-9B48-83402C2AC4B6 Q38804663-D30E97CD-33E2-41D5-B941-E74E85820422 Q38928337-04531707-6DEF-4191-ABA1-20E1F7FFF63F Q49212311-7F4E7179-F2F0-4117-A596-7B04BD06B6A9 Q50967834-D23FC89F-4C90-4A1F-8332-D6744985F5C4 Q55039164-C58582AC-8074-4815-A512-0FE65749C00B Q58702997-E9B127EE-6C9B-4A5E-98D6-6E28CDCB93F6

P2860

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

http://www.wikidata.org/entity/Q34490667

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@ast

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@en

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@nl

type

label

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@ast

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@en

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@nl

prefLabel

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@ast

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@en

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.

@nl

P1433

Q34490667-46DCF21B-0971-44E9-AD1C-3DA4AA8BC338

P1476

Q34490667-6ECC1B6A-2791-4DD9-ACDF-3C67BA0B950F

P2093

Q34490667-DECE15E1-B5EB-4D40-A934-AE744E311DEE

Q34490667-EE49F3A8-20BB-45AB-8E0E-0B51C7AEC748

Q34490667-FDCD4F4C-AFDD-42C9-950E-D4A0BF2797F0

P2860

Q34490667-049D8FAD-F3C0-4BE7-BEE7-24C33E6B204E

Q34490667-0A59E667-2AA9-4AD2-A38F-D99A8E7D5743

Q34490667-10314E66-8FF5-42B0-97CA-9C643170DFEA

Q34490667-12D7CEED-224F-4006-B6AC-6E070654B3CA

Q34490667-14A70949-7BB2-417C-A097-ABF40EB783BB

Q34490667-16FCD6A1-8060-4F44-9A36-E08348C94610

Q34490667-239CE9B9-08D3-41E5-BE1B-DD3778060BCE

Q34490667-28554F86-05C9-435A-AD1F-1DEBE87D24F1

Q34490667-28AE07F3-1FE3-4FB3-AF24-E15C65030393

Q34490667-2B89C348-B117-4F66-B405-690FF16A7EB0

P304

Q34490667-22BDA8D4-1BD1-457B-B841-3C4EA99D00A4

P31

Q34490667-D22A92F3-C543-4A21-BBAA-D586A2699B23

P356

Q34490667-D32EAF89-9D09-4FD4-90BB-557F86D94DEC

P433

Q34490667-4C2A7F5C-56F8-4816-BD31-018554F9CA06

P478

Q34490667-4E774D7C-4B13-4F36-997A-75DD9D14EF71

P50

Q34490667-174FED64-B4A5-4C4B-8AE3-E943EED400B5

P577

Q34490667-594364BC-5B86-4765-A999-5A4ACF05C1F5

P698

Q34490667-5D2BFBB7-18D3-4E27-92AC-69138294A2BE

P932

Q34490667-C987C6BD-8BC0-4355-B8B7-BDD341589A30

P356

1061186X.2014.950666

P1433

Journal of Drug Targeting

P1476

A polypeptide drug carrier for maternal delivery and prevention of fetal exposure

@en

P2093

Eric M George

http://www.w3.org/2001/XMLSchema#string

Grant G Robinson

http://www.w3.org/2001/XMLSchema#string

Huiling Liu

http://www.w3.org/2001/XMLSchema#string

P2860

A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus

Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist

The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans

A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term

Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection

Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model

Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.

P304

935-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2014.950666

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25148609

http://www.w3.org/2001/XMLSchema#string

P932

4227969

http://www.w3.org/2001/XMLSchema#string